Cyclerion Therapeutics, Inc. enterprise value

The Enterprise Value as of October 2026 (TTM) for Cyclerion Therapeutics, Inc. (CYCN) is 145.58M

According to Cyclerion Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 145.58M. This represents a change of 2.75% compared to the average of 5.10M of the last 4 quarters.

Cyclerion Therapeutics, Inc. (CYCN) Historical Enterprise Value (quarterly & annually)

How has CYCN Enterprise Value performed in the past?

The mean historical Enterprise Value of Cyclerion Therapeutics, Inc. over the last ten years is 85.23M. The current 145.58M Enterprise Value has changed 70.82% with respect to the historical average. Over the past ten years (40 quarters), CYCN's Enterprise Value was at its highest in in the March 2019 quarter at 625.63M. The Enterprise Value was at its lowest in in the June 2022 quarter at -7632083.36.

Cyclerion Therapeutics, Inc. (CYCN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cyclerion Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cyclerion Therapeutics, Inc. (CYCN) Average Enterprise Value

How has CYCN Enterprise Value performed in the past?

The current Enterprise Value of Cyclerion Therapeutics, Inc. (CYCN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cyclerion Therapeutics, Inc. (CYCN) Enterprise Value vs. Peers

How is CYCN’s Enterprise Value compared to its peers?

Cyclerion Therapeutics, Inc.’s Enterprise Value is greater than Alaunos Therapeutics, Inc. (6.43M), greater than XTL Biopharmaceuticals Ltd. (4.58M), greater than Polyrizon Ltd. (4.06M), greater than Quoin Pharmaceuticals, Ltd. (4.85M), greater than Pasithea Therapeutics Corp. (-33290412.00), greater than Radiopharm Theranostics Limited (7.69M), less than VYNE Therapeutics Inc. (155.02M), greater than NovaBay Pharmaceuticals, Inc. (44.27M), greater than Addex Therapeutics Ltd (2.04M), greater than AIM ImmunoTech Inc. (599.65K),

Build a custom stock screener for Cyclerion Therapeutics, Inc. (CYCN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclerion Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cyclerion Therapeutics, Inc. (CYCN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cyclerion Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.